Try our beta test site

Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer (LAPADO)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prof Dirk Elling, Sana-Klinikum Lichtenberg
ClinicalTrials.gov Identifier:
NCT01172223
First received: July 28, 2010
Last updated: November 1, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)